Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Chromosomal differences affect how muscle cells respond to testosterone.

Androgens increase cervical cancer risk and affect its development.

Anabolic-androgenic steroids can damage the brain, causing mood and cognitive problems.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Sex-limited chromosomes can affect traits not related to reproduction.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Females generally have stronger immune responses than males due to the X chromosome.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.